Unc-ch News | WRAL TechWire
Unc-ch News

Unc-ch News


Posts by Unc-ch News


UNC researchers find compound that could stop brain tumors

Editor’s note: WRAL Local Tech Wire publishes selected stories from the news services of various universities as part of its UniversityTech coverage. LTW is enhancing significantly its coverage of scientific and research efforts at regional universities where many of tomorrow’s discoveries are being made and the foundations of new companies are in the process of being created. CHAPEL HILL, N.C. – Researchers at the have identified a compound that could be modified to treat one of the most deadly types of cancer, and discovered how a particular gene mutation contributes to tumor growth. The findings and potential treatment apply...

Read More

A salute to an RTP founder – William F. Little

Editor’s note: Local Tech Wire is publishing the full obituary of William Little, a founder of Research Triangle Park and a longtime professor and administrator at UNC-Chapel Hill, as provided by UNC-CH’s news service with respect for Mr. Little’s many contributions to education and development of RTP as well as RTI International. CHAPEL HILL, N.C. – William F. “Bill” Little, a member of the University of North Carolina at Chapel Hill faculty for more than 40 years, a former vice president of the UNC system and a visionary leader who helped guide the development of the state’s Research Triangle...

Read More

UNC-CH may have discovered breakthrough to combat transplant rejection

Editor’s note: WRAL Local Tech Wire publishes selected stories from the news services of various universities as part of its UniversityTech coverage. LTW is enhancing significantly its coverage of scientific and research efforts at regional universities where many of tomorrow’s discoveries are being made and the foundations of new companies are in the process of being created. CHAPEL HILL, N.C. – To prevent the rejection of newly transplanted organs and cells, patients must take medicines that weaken their entire immune systems. Such potentially life-saving treatments can, paradoxically, leave those receiving them susceptible to life-threatening infections. Now researchers at the...

Read More

New genomic test may guide breast cancer treatment choices, UNC says

Editor’s note: WRAL Local Tech Wire publishes selected stories from the news services of various universities as part of its UniversityTech coverage. LTW is enhancing significantly its coverage of scientific and research efforts at regional universities where many of tomorrow’s discoveries are being made and the foundations of new companies are in the process of being created. CHAPEL HILL, N.C. – Scientists at the University of North Carolina at Chapel Hill have developed a new genomic test designed to help clinicians predict which breast cancer patients are most likely to survive the disease and which treatments may be most...

Read More

UNC study links chemotherapy effectiveness, time of delivery

Editor’s note: WRAL Local Tech Wire publishes selected stories from the news services of various universities as part of its UniversityTech coverage. LTW is enhancing significantly its coverage of scientific and research efforts at regional universities where many of tomorrow’s discoveries are being made and the foundations of new companies are in the process of being created. CHAPEL HILL, N.C. — For years, research has hinted that the time of day that cancer patients receive chemotherapy can impact their chances of survival. But the lack of a clear scientific explanation for this finding has kept clinicians from considering timing...

Read More

UNC-CH scientists teach enzyme to make synthetic anticoagulant heparin in more varieties

Editor’s note: WRAL Local Tech Wire publishes selected stories from the news services of various universities as part of its UniversityTech coverage. LTW is enhancing significantly its coverage of scientific and research efforts at regional universities where many of tomorrow’s discoveries are being made and the foundations of new companies are in the process of being created. CHAPEL HILL, N.C. – Scientists at the University of North Carolina at Chapel Hill have learned to customize a key human enzyme responsible for producing heparin, opening the door to a more effective synthetic anticoagulant as well as treatments for other conditions....

Read More